Oceanpine Capital
Oceanpine Capital is a professional investment management firm dedicated to long-term investment with a focus on value creation.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Oceanpine Capital Information
Geographic Data
Address: 1 Garden Road
City: Central
State: hong kong special administrative region
Zip: 999077
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$912M
Social
Linkedin
Crunchbase
Metrics
6,809,259Website Global Rank
277Website Monthly Traffic
Twitter Followers
Description
Oceanpine Capital is a professional investment management firm dedicated to long-term investment with a focus on value creation. We provide long-term capital and professional value-added services to high-growth enterprises and start-up companies. Oceanpine Capital is headquartered in Hong Kong with offices in Beijing and San Francisco. We focus on investment opportunities in the TMT, consumption upgrade, advanced manufacturing, and healthcare sectors. We mainly invest in private companies with rapid growth, but also look at some opportunities in public companies. Our professional team consists of entrepreneurs, investment professionals, investment bankers and company executives with proven track records. As a team, we stand out in terms of providing strategic resources support and professional value-added services to our investee companies along with our capital.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2019 | Enflame | Series A | 0 |
| 3/2021 | JuLive.com | Series C | 61.6M |
| 5/2021 | Weilong Foods | Series A | 558M |
| 5/2020 | Enflame | Series B | 98.8M |
| 6/2021 | Tongshu Gene | Series C | 78.1M |
| 3/2022 | Shenzhen Shifeng | Series A | 0 |
| 4/2021 | TechnoDerma Medicines | Series A | - |
| 9/2020 | XtalPi | Series C | 318.8M |
| 2/2019 | Horizon Robotics | Series B | 0 |
| 12/2021 | OrthoGuard | Series A | - |
| 11/2022 | SIRUI | Venture Round | - |
| 8/2020 | Sinovent | Series C | 144.7M |
| 9/2021 | MingMed | Series A | 0 |
| 8/2021 | Svolt Energy Technology Co., Ltd. | Series B | 0 |
| 8/2022 | Enflame | Series C | - |
| 12/2021 | Chipone Technology | Series E | 0 |
| 9/2022 | Qinghai Lihao | Series B | 306.5M |
| 7/2018 | Tiger Brokers | Series C | 80M |
| 8/2020 | Triumvira Immunologics | Series A | 0 |
| 9/2020 | Creative Biosciences | Series C | 87.9M |
| 2/2021 | Clover Biopharmaceuticals | Series C | 230M |
| 8/2020 | HireEZ | Series B | 13M |
| 12/2021 | Yuchuang Semiconductor | Series A | 15.7M |
| 8/2018 | 51zhaoyou.com | Series C | 150M |
| 2/2021 | Teon Therapeutics | Series A | 0 |
| 10/2019 | Ansun BioPharma | Series B | 100M |
| 3/2020 | Apexigen | Series C | 65M |
| 5/2022 | Aqronos | Series A | - |
| 2/2022 | Lianshu Technology | Angel Round | 0 |
| 1/2023 | Kuixin Technology | Series A | 14.8M |
| 5/2018 | Ansun BioPharma | Series A | 85M |
| 2/2021 | Yisheng Biopharma | Series B | 0 |
| 3/2021 | Immune-Onc Therapeutics | Series B | 0 |
| 2/2022 | Clounix | Series A | 0 |
| 10/2018 | Inspirna, Inc.(formerly Rgenix, Inc.) | Series C | 40M |
| 5/2022 | Aqronos | Series A | - |
| 3/2022 | Shenzhen Shifeng | Series A | 0 |
| 2/2022 | Clounix | Series A | 0 |
| 2/2022 | Lianshu Technology | Angel Round | 0 |
| 12/2021 | OrthoGuard | Series A | - |
| 12/2021 | Yuchuang Semiconductor | Series A | 0 |
| 12/2021 | Chipone Technology | Series E | 0 |
| 9/2021 | MingMed | Series A | 0 |
| 8/2021 | Svolt Energy Technology Co. | Series B | 0 |
| 6/2021 | Tongshu Gene | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
